Atlas Trials

Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant

Clinical trial NCT03093740 · WITHDRAWN

Trial details

NCT number
NCT03093740
Sponsor
Massachusetts General Hospital
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Renal Failure ChronicHepatitis C
Start date
2018-10-01
Primary completion
2020-12-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.